UnitedHealth Group (UNH) risk factors, FY2024 10-K

Risks Related to Our Business and Our Industry

1. 01If we fail to estimate, price for and manage our medical costs or design benefits in an effective manner, the profitability of our risk-based products and services could decline and could materially and adversely affect our results of operations, financial position and cash flows
2. 02If we fail to maintain properly the integrity or availability of our data or successfully consolidate, integrate, upgrade or expand our existing information systems, or if our technology products do not operate as intended, our business could be materially and adversely affected
3. 03If we fail to develop and maintain satisfactory relationships with health care payers, physicians, hospitals and other service providers, our business could be materially and adversely affected
4. 04If we fail to compete effectively to maintain or increase our market share, including maintaining or increasing enrollments in businesses providing health benefits, our results of operations, financial position and cash flows could be materially and adversely affected
5. 05We are routinely subject to various private party and governmental legal actions and investigations, which could damage our reputation and, if resolved unfavorably, could result in substantial penalties or monetary damages and materially and adversely affect our results of operations, financial position and cash flows
6. 06Our business could suffer, and our results of operations, financial position and cash flows could be materially and adversely affected, if we fail to successfully manage our strategic alliances, or to complete, manage or integrate acquisitions and other significant strategic transactions or relationships
7. 07We are subject to risks associated with public health crises arising from large-scale medical emergencies, pandemics, natural disasters and other extreme events, which have had and could have an adverse effect on our business, results of operations, financial condition and financial performance
8. 08Our sales performance will suffer if we do not adequately attract, retain and provide support to a network of independent producers and consultants
9. 09Our businesses are subject to risks associated with unfavorable economic conditions
10. 10Our failure to attract, develop, retain, and manage the succession of key employees and executives could adversely affect our business, results of operations and future performance
11. 11Our investment portfolio may sustain losses which could adversely affect our profitability
12. 12If the value of our intangible assets is materially impaired, our results of operations, equity and credit ratings could be materially and adversely affected
13. 13If we are not able to protect our proprietary rights to our databases, software and related products, or other intellectual property, our ability to market our knowledge and information-related businesses could suffer
14. 14Any downgrades in our credit ratings could increase our borrowing and operating costs

Risks Related to the Regulation of Our Business

1. 15Our business activities in the United States and other countries are highly regulated and new laws or regulations or changes in existing laws or regulations or their enforcement or application could materially and adversely affect our business
2. 16insurance entities and other insurers to the risk they would be required to pay a portion of an impaired or insolvent insurance company’s claims through state guaranty associations
3. 17Our pharmacy care services businesses face regulatory and operational risks and uncertainties which may differ from the risks of our other businesses
4. 18Some of our businesses are also subject to the Payment Card Industry Data Security Standard, which is a multifaceted security standard designed to protect payment card account data
5. 19Restrictions on our ability to obtain funds from our regulated subsidiaries could materially and adversely affect our ability to reinvest in our business, service our debt and return capital to our shareholders